Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2009

01-08-2009 | Article

Antibiotic prescribing over the last 16 years: fewer antibiotics but the spectrum is broadening

Authors: C. Llor, J. M. Cots, M. J. Gaspar, M. Alay, N. Rams

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2009

Login to get access

Abstract

The purpose of this study was to quantify the antibiotics prescribed in the outpatient setting of all primary health care professionals in Catalonia during 1992–2007. We calculated prescribed defined daily doses per 1,000 inhabitants and day (DID) from data provided by the Catalonian Health Service. The antibiotics analysed belonged to the J01 group (ATC/DDD classification). The overall prescribing of antibacterials has decreased by 11.9% during this period (1992: 16.75 DID, 2007: 14.75 DID). During this 16-year period, an increase was observed for penicillins (from 46.1% in 1992 to 59.6% in 2007) and for quinolones (from 13.3% to 15.7%). The prescription of cephalosporins remained steady and, conversely, a decrease in macrolides was found (from 14.8% to 12.2%). The leading antibiotic prescribed in 2007 was amoxicillin plus clavulanic acid (5.15 DID), followed by amoxicillin (2.95 DID). The former has increased by 84.4% since 2002. Penicillin V prescribing reached a peak in 2007 with 0.034 DID. There has been a slight reduction in antibiotic prescription in this 16-year study, with an increase of penicillins, mainly at the expense of those of broader antibacterial spectrum. Awareness of the rational use of antibiotics is mandatory, basically aimed at reducing the overall prescribing of antibiotics and encouraging those with a narrower spectrum.
Literature
2.
go back to reference Goossens H, Ferech M, Coenen S et al; European Surveillance of Antimicrobial Consumption Project Group (2007) Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis 44:1091–1095. doi:10.1086/512810 PubMedCrossRef Goossens H, Ferech M, Coenen S et al; European Surveillance of Antimicrobial Consumption Project Group (2007) Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis 44:1091–1095. doi:10.​1086/​512810 PubMedCrossRef
3.
go back to reference Ferech M, Coenen S, Malhotra-Kumar S et al; ESAC Project Group (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother 58:401–407. doi:10.1093/jac/dkl188 PubMedCrossRef Ferech M, Coenen S, Malhotra-Kumar S et al; ESAC Project Group (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother 58:401–407. doi:10.​1093/​jac/​dkl188 PubMedCrossRef
5.
go back to reference Goossens H, Ferech M, Vander Stichele R et al; ESAC Project Group (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579–587PubMed Goossens H, Ferech M, Vander Stichele R et al; ESAC Project Group (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579–587PubMed
6.
go back to reference Bronzwaer SL, Cars O, Buchholz U et al; European Antimicrobial Resistance Surveillance System (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8:278–282PubMedCrossRef Bronzwaer SL, Cars O, Buchholz U et al; European Antimicrobial Resistance Surveillance System (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8:278–282PubMedCrossRef
9.
go back to reference Smucny J, Fahey T, Becker L et al (2004) Antibiotics for acute bronchitis. Cochrane Database Syst Rev 4:CD000245PubMed Smucny J, Fahey T, Becker L et al (2004) Antibiotics for acute bronchitis. Cochrane Database Syst Rev 4:CD000245PubMed
11.
go back to reference Little PS, Gould C, Williamson I et al (1997) Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ 315:350–352PubMed Little PS, Gould C, Williamson I et al (1997) Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ 315:350–352PubMed
15.
go back to reference World Health Organization Collaborating Centre for Drug Statistics Methodology (2006) Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Doses (DDDs). WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway. Home page at: doi:http://www.whocc.no/atcddd/ World Health Organization Collaborating Centre for Drug Statistics Methodology (2006) Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Doses (DDDs). WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway. Home page at: doi:http://​www.​whocc.​no/​atcddd/​
16.
go back to reference Capellà D (1993) Descriptive tools and analysis. WHO Reg Publ Eur Ser 45:55–78PubMed Capellà D (1993) Descriptive tools and analysis. WHO Reg Publ Eur Ser 45:55–78PubMed
18.
go back to reference Lázaro E, Madurga M, de Abajo FJ (2002) Evolución del consumo de antibióticos en España, 1985–2000. Med Clin (Barc) 118:561–568 Lázaro E, Madurga M, de Abajo FJ (2002) Evolución del consumo de antibióticos en España, 1985–2000. Med Clin (Barc) 118:561–568
19.
go back to reference Campos J, Ferech M, Lázaro E et al (2007) Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother 60:698–701. doi:10.1093/jac/dkm248 PubMedCrossRef Campos J, Ferech M, Lázaro E et al (2007) Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother 60:698–701. doi:10.​1093/​jac/​dkm248 PubMedCrossRef
21.
go back to reference Ripoll Lozano MA, Jiménez Arce JI, Pedraza Dueñas A (2007) Variabilidad en la prescripción de antibióticos en la provincia de Ávila. Rev Esp Quimioter 20:44–50PubMed Ripoll Lozano MA, Jiménez Arce JI, Pedraza Dueñas A (2007) Variabilidad en la prescripción de antibióticos en la provincia de Ávila. Rev Esp Quimioter 20:44–50PubMed
23.
go back to reference Andrade RJ, Lucena MI, Fernández MC et al (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512–521PubMed Andrade RJ, Lucena MI, Fernández MC et al (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512–521PubMed
24.
go back to reference Sabaté M, Ibáñez L, Pérez E et al (2007) Risk of acute liver injury associated with the use of drugs: a multicentre population survey. Aliment Pharmacol Ther 25:1401–1409PubMedCrossRef Sabaté M, Ibáñez L, Pérez E et al (2007) Risk of acute liver injury associated with the use of drugs: a multicentre population survey. Aliment Pharmacol Ther 25:1401–1409PubMedCrossRef
25.
go back to reference Ferech M, Coenen S, Dvorakova K et al; ESAC Project Group (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe. J Antimicrob Chemother 58:408–412. doi:10.1093/jac/dkl186 PubMedCrossRef Ferech M, Coenen S, Dvorakova K et al; ESAC Project Group (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe. J Antimicrob Chemother 58:408–412. doi:10.​1093/​jac/​dkl186 PubMedCrossRef
26.
go back to reference Elseviers MM, Ferech M, Vander Stichele RH et al; ESAC Project Group (2007) Antibiotic use in ambulatory care in Europe (ESAC data 1997–2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf 16:115–123. doi:10.1002/pds.1244 PubMedCrossRef Elseviers MM, Ferech M, Vander Stichele RH et al; ESAC Project Group (2007) Antibiotic use in ambulatory care in Europe (ESAC data 1997–2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf 16:115–123. doi:10.​1002/​pds.​1244 PubMedCrossRef
27.
go back to reference Coenen S, Ferech M, Malhotra-Kumar S et al; ESAC Project Group (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. J Antimicrob Chemother 58:418–422. doi:10.1093/jac/dkl184 PubMedCrossRef Coenen S, Ferech M, Malhotra-Kumar S et al; ESAC Project Group (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. J Antimicrob Chemother 58:418–422. doi:10.​1093/​jac/​dkl184 PubMedCrossRef
28.
go back to reference van Duijn HJ, Kuyvenhoven MM, Butler CC et al (2005) Variation in outpatient antibiotic use in three European countries: exploration of possible determinants. Eur J Gen Pract 11:139–140PubMedCrossRef van Duijn HJ, Kuyvenhoven MM, Butler CC et al (2005) Variation in outpatient antibiotic use in three European countries: exploration of possible determinants. Eur J Gen Pract 11:139–140PubMedCrossRef
29.
go back to reference Steinman MA, Gonzales R, Linder JA et al (2003) Changing use of antibiotics in community-based outpatient practice, 1991–1999. Ann Intern Med 138:525–533PubMed Steinman MA, Gonzales R, Linder JA et al (2003) Changing use of antibiotics in community-based outpatient practice, 1991–1999. Ann Intern Med 138:525–533PubMed
31.
go back to reference Rao GG, Patel M (2009) Urinary tract infection in hospitalized elderly patients in the United Kingdom: the importance of making an accurate diagnosis in the post broad-spectrum antibiotic era. J Antimicrob Chemother 63:5–6. doi:10.1093/jac/dkn458 Rao GG, Patel M (2009) Urinary tract infection in hospitalized elderly patients in the United Kingdom: the importance of making an accurate diagnosis in the post broad-spectrum antibiotic era. J Antimicrob Chemother 63:5–6. doi:10.​1093/​jac/​dkn458
32.
go back to reference Finch R, Hunter PA (2006) Antibiotic resistance—action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12–13 December 2005. J Antimicrob Chemother 58(Suppl S1):i3–i22PubMedCrossRef Finch R, Hunter PA (2006) Antibiotic resistance—action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12–13 December 2005. J Antimicrob Chemother 58(Suppl S1):i3–i22PubMedCrossRef
33.
go back to reference Worrall G, Hutchinson J, Sherman G et al (2007) Diagnosing streptococcal sore throat in adults: randomized controlled trial of in-office aids. Can Fam Physician 53:667–671PubMed Worrall G, Hutchinson J, Sherman G et al (2007) Diagnosing streptococcal sore throat in adults: randomized controlled trial of in-office aids. Can Fam Physician 53:667–671PubMed
Metadata
Title
Antibiotic prescribing over the last 16 years: fewer antibiotics but the spectrum is broadening
Authors
C. Llor
J. M. Cots
M. J. Gaspar
M. Alay
N. Rams
Publication date
01-08-2009
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2009
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0719-3

Other articles of this Issue 8/2009

European Journal of Clinical Microbiology & Infectious Diseases 8/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.